|
US5744500A
(en)
*
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL118836A
(en)
|
1996-07-11 |
2001-01-11 |
Teva Pharma |
Pharmaceutical compositions comprising s-(-)-n-propargyl-1-aminoindan
|
|
WO2002069977A1
(en)
|
2001-03-01 |
2002-09-12 |
Hollis-Eden Pharmaceuticals, Inc. |
Use of certain steroids for treatment of blood cell deficiencies
|
|
CA2496867A1
(en)
|
2002-08-28 |
2004-03-11 |
Hollis-Eden Pharmaceuticals, Inc. |
Therapeutic treatment methods
|
|
CA2505476C
(en)
*
|
2002-11-07 |
2015-05-26 |
Technion Research And Development Foundation Ltd. |
Neuroprotective iron chelators and pharmaceutical compositions comprising them
|
|
US7396860B2
(en)
|
2002-11-15 |
2008-07-08 |
Teva Pharmaceutical Industries, Ltd. |
Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
|
|
US8097608B2
(en)
*
|
2003-11-25 |
2012-01-17 |
Technion Research And Development Foundation Ltd. |
Methods for treatment of cardiovascular disorders and diseases
|
|
WO2005051371A1
(en)
|
2003-11-25 |
2005-06-09 |
Technion Research & Development Foundation Ltd. |
Compositions and methods for treatment of cardiovascular disorders and diseases
|
|
JP2005232148A
(ja)
*
|
2004-02-03 |
2005-09-02 |
Technion Research & Development Foundation Ltd |
神経保護剤としてプロパルギルアミンの使用
|
|
EP1778196A4
(en)
*
|
2004-07-26 |
2008-12-17 |
Teva Pharma |
PHARMACEUTICAL DOSAGES CONTAINING RASAGILINE
|
|
US20060025446A1
(en)
*
|
2004-07-27 |
2006-02-02 |
Jeffrey Sterling |
Propargyl nitroxides and indanyl nitroxides and their use for the treatment of neurologic diseases and disorders
|
|
CA2582231A1
(en)
|
2004-09-29 |
2006-10-19 |
Hollis-Eden Pharmaceuticals, Inc. |
Steroid analogs and uses
|
|
SI1848415T1
(sl)
*
|
2005-02-17 |
2013-08-30 |
Teva Pharmaceutical Industries Ltd. |
Kombinacijska terapija z glatiramer acetatom in razagilinom za zdravljenje muliple skleroze
|
|
KR20170023211A
(ko)
|
2005-02-23 |
2017-03-02 |
테바 파마슈티컬 인더스트리즈 리미티드 |
함량 균일성이 개선된 라사길린 제형
|
|
US8263655B2
(en)
|
2005-10-06 |
2012-09-11 |
Technion Research And Development Foundation Ltd |
Methods for treatment of renal failure
|
|
CN101622225B
(zh)
*
|
2005-11-17 |
2015-04-15 |
泰华制药工业有限公司 |
炔丙基氨基茚分离方法
|
|
US7572834B1
(en)
|
2005-12-06 |
2009-08-11 |
Teva Pharmaceutical Industries, Ltd. |
Rasagiline formulations and processes for their preparation
|
|
CA2634166C
(en)
|
2005-12-09 |
2016-03-29 |
Marta Weinstock-Rosin |
Use of low-dose ladostigil for neuroprotection
|
|
JP5701485B2
(ja)
|
2006-02-21 |
2015-04-15 |
テバ ファーマシューティカル インダストリーズ リミティド |
多系統萎縮症の治療のためのラサギリンの使用
|
|
TW200744576A
(en)
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
CA2646250A1
(en)
|
2006-04-03 |
2007-10-18 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of restless legs syndrome
|
|
EP1892233A1
(de)
*
|
2006-08-18 |
2008-02-27 |
Ratiopharm GmbH |
Neue Salze des Wirkstoffs Rasagilin
|
|
EA016820B1
(ru)
*
|
2006-12-14 |
2012-07-30 |
Тева Фармасьютикал Индастриз, Лтд. |
Кристаллическое твердое основание разагилина
|
|
KR101077835B1
(ko)
*
|
2006-12-14 |
2011-10-28 |
테바 파마슈티컬 인더스트리즈 리미티드 |
라사길린의 타닌산염
|
|
EP1987816A1
(de)
*
|
2007-04-30 |
2008-11-05 |
Ratiopharm GmbH |
Adsorbate eines Rasagilinsalzes mit einem wasserlöslichen Hilfsstoff
|
|
EP2194780A4
(en)
*
|
2007-09-05 |
2010-10-27 |
Teva Pharma |
METHOD FOR TREATING GLAUCOMA BY RASAGILINE
|
|
US8188149B2
(en)
*
|
2007-09-17 |
2012-05-29 |
Teva Pharmaceutical Industries, Ltd. |
Use of R(+)-N-propargy1-1-aminoindan to treat or prevent hearing loss
|
|
SG187455A1
(en)
*
|
2008-01-11 |
2013-02-28 |
Teva Pharma |
Rasagiline formulations, their preparation and use
|
|
WO2009122351A2
(en)
*
|
2008-04-01 |
2009-10-08 |
Kangwon National University |
Anti-parkinsonian compounds mppe
|
|
JP2011524353A
(ja)
*
|
2008-06-10 |
2011-09-01 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリン軟ゼラチンカプセル
|
|
BRPI0909894A2
(pt)
*
|
2008-06-13 |
2015-07-28 |
Teva Pharma |
"método de redução da velocidade de progressão de mal de parkinson em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão de mal de parkinson, método de atraso da necessidade de terapia antiparkinsoniana sintomática em um paciente de mal de parkinson em estágio inicial, método de redução do risco de um paciente com mal de parkinson que necessita de terapia antiparkinsoniana, método de redução do declínio funcional de um paciente com mal de parkinson em estágio inicial, método de redução do declínio funcional em um paciente com mal de parkinson, método de tratamento de um paciente que exibe sinais iniciais de mal de parkinson, método de redução da fadiga em um paciente com mal de parkinson em estágio inicial, método de redução da velocidade de progressão clínica e tratamento de sintomas de mal de parkinson em um paciente com mal de parkinson, rasagilina ou um sal farmaceuticamente aceitável de rasagilina, composição farmacêutica.
|
|
AU2009260733B2
(en)
*
|
2008-06-19 |
2015-01-29 |
Teva Pharmaceutical Industries, Ltd. |
Process for purifying rasagiline base
|
|
BRPI0909997A2
(pt)
|
2008-06-19 |
2015-10-27 |
Teva Pharma |
r(+)-n-propargil-1-aminoindano cristalino, composição farmacêutica, processo de secagem de r(+)-n-propargil-1-aminoindano sólido, processo de preparação de uma composição farmacêutica, processo de produção de um lote validado de um produto de farmaco que contém r(+)-n-propargil-1-aminoindano cristalino e pelo menos um veículo farmaceuticamente aceitável para distribuição e processo de prudução de r(+)-n-propargil-1-aminoindano cristalino
|
|
US8080584B2
(en)
*
|
2009-01-23 |
2011-12-20 |
Teva Pharmaceuticals Industries, Ltd. |
Delayed release rasagiline citrate formulation
|
|
JP2012532843A
(ja)
|
2009-07-09 |
2012-12-20 |
ラティオファーム ゲーエムベーハー |
ラサギリンの塩およびその製剤
|
|
RU2607595C2
(ru)
|
2010-02-03 |
2017-01-10 |
Фарма Ту Б Лтд. |
Составы разагилина с пролонгированным высвобождением и их применение
|
|
JP2013537530A
(ja)
|
2010-07-27 |
2013-10-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
ラサギリンシトレートの分散物
|
|
WO2012015950A1
(en)
|
2010-07-27 |
2012-02-02 |
Teva Pharmaceutical Industries Ltd. |
Use of rasagiline for the treatment of olfactory dysfunction
|
|
EA201490761A1
(ru)
|
2011-10-10 |
2014-11-28 |
Тева Фармасьютикал Индастриз Лтд. |
R(+)-n-формилпропаргиламиноиндан
|
|
BR112014008552A2
(pt)
|
2011-10-10 |
2017-04-18 |
Teva Pharma |
r(+)-n-metil-propargilaminoindano
|
|
WO2014028868A1
(en)
|
2012-08-17 |
2014-02-20 |
Teva Pharmaceutical Industries Ltd. |
Parenteral formulation of rasagiline
|
|
CN104177610A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN104177611A
(zh)
*
|
2013-05-27 |
2014-12-03 |
韩文毅 |
一种非线性的聚合物及其制备和用途
|
|
CN111333517A
(zh)
*
|
2018-12-19 |
2020-06-26 |
上海奥博生物医药技术有限公司 |
一种制备雷沙吉兰的改进方法
|